INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts INMB Hot Sheet
Join SI Premium – FREE
INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Herc Holding (HRI) to Overweight
- Goldman Sachs Upgrades National Australia Bank Ltd. (NAB:AU) (NABZY) to Neutral
- Morgan Stanley Starts NTG Nordic Transport Group A/S (NTG:DC) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
